Peter Cronin1, Michael J McCarthy2, Andrew S P Lim3, David P Salmon1, Douglas Galasko1, Eliezer Masliah4, Philip L De Jager5, David A Bennett6, Paula Desplats7. 1. Department of Neurosciences, University of California San Diego, La Jolla, CA, USA. 2. Psychiatry Service, Veterans Affairs San Diego Health Care System, San Diego, CA, USA; Department of Psychiatry, University of California San Diego, La Jolla, CA, USA. 3. Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. 4. Department of Neurosciences, University of California San Diego, La Jolla, CA, USA; Department of Pathology, University of California San Diego, La Jolla, CA, USA. 5. Departments of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA. 6. Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA. 7. Department of Neurosciences, University of California San Diego, La Jolla, CA, USA; Department of Pathology, University of California San Diego, La Jolla, CA, USA. Electronic address: pdesplat@ucsd.edu.
Abstract
INTRODUCTION: Circadian alterations are prevalent in Alzheimer's disease (AD) and may contribute to cognitive impairment, behavioral symptoms, and neurodegeneration. Epigenetic mechanisms regulate the circadian clock, and changes in DNA methylation have been reported in AD brains, but the pathways that mediate circadian deregulation in AD are incompletely understood. We hypothesized that aberrant DNA methylation may affect circadian rhythms in AD. METHODS: We investigated DNA methylation, transcription, and expression of BMAL1, a positive regulator of the circadian clock, in cultured fibroblasts and brain samples from two independent cohorts of aging and AD. RESULTS: DNA methylation modulated rhythmic expression of clock genes in cultured fibroblasts. Moreover, rhythmic methylation of BMAL1 was altered in AD brains and fibroblasts and correlated with transcription cycles. DISCUSSION: Our results indicate that cycles of DNA methylation contribute to the regulation of BMAL1 rhythms in the brain. Hence, aberrant epigenetic patterns may be linked to circadian alterations in AD.
INTRODUCTION: Circadian alterations are prevalent in Alzheimer's disease (AD) and may contribute to cognitive impairment, behavioral symptoms, and neurodegeneration. Epigenetic mechanisms regulate the circadian clock, and changes in DNA methylation have been reported in AD brains, but the pathways that mediate circadian deregulation in AD are incompletely understood. We hypothesized that aberrant DNA methylation may affect circadian rhythms in AD. METHODS: We investigated DNA methylation, transcription, and expression of BMAL1, a positive regulator of the circadian clock, in cultured fibroblasts and brain samples from two independent cohorts of aging and AD. RESULTS: DNA methylation modulated rhythmic expression of clock genes in cultured fibroblasts. Moreover, rhythmic methylation of BMAL1 was altered in AD brains and fibroblasts and correlated with transcription cycles. DISCUSSION: Our results indicate that cycles of DNA methylation contribute to the regulation of BMAL1 rhythms in the brain. Hence, aberrant epigenetic patterns may be linked to circadian alterations in AD.
Authors: Giles E Duffield; Jonathan D Best; Bernhard H Meurers; Anton Bittner; Jennifer J Loros; Jay C Dunlap Journal: Curr Biol Date: 2002-04-02 Impact factor: 10.834
Authors: Michael J McCarthy; Melissa J Le Roux; Heather Wei; Stephen Beesley; John R Kelsoe; David K Welsh Journal: Neuropharmacology Date: 2015-10-22 Impact factor: 5.250
Authors: R Y Liu; J N Zhou; W J Hoogendijk; J van Heerikhuize; W Kamphorst; U A Unmehopa; M A Hofman; D F Swaab Journal: J Neuropathol Exp Neurol Date: 2000-04 Impact factor: 3.685
Authors: Steven A Brown; Dieter Kunz; Amelie Dumas; Pål O Westermark; Katja Vanselow; Amely Tilmann-Wahnschaffe; Hanspeter Herzel; Achim Kramer Journal: Proc Natl Acad Sci U S A Date: 2008-01-28 Impact factor: 11.205
Authors: Mason A Israel; Shauna H Yuan; Cedric Bardy; Sol M Reyna; Yangling Mu; Cheryl Herrera; Michael P Hefferan; Sebastiaan Van Gorp; Kristopher L Nazor; Francesca S Boscolo; Christian T Carson; Louise C Laurent; Martin Marsala; Fred H Gage; Anne M Remes; Edward H Koo; Lawrence S B Goldstein Journal: Nature Date: 2012-01-25 Impact factor: 49.962
Authors: Brian V Lananna; Collin J Nadarajah; Mariko Izumo; Michelle R Cedeño; David D Xiong; Julie Dimitry; Chak Foon Tso; Celia A McKee; Percy Griffin; Patrick W Sheehan; Jeffery A Haspel; Ben A Barres; Shane A Liddelow; Joseph S Takahashi; Ilia N Karatsoreos; Erik S Musiek Journal: Cell Rep Date: 2018-10-02 Impact factor: 9.423
Authors: Erik S Musiek; Meghana Bhimasani; Margaret A Zangrilli; John C Morris; David M Holtzman; Yo-El S Ju Journal: JAMA Neurol Date: 2018-05-01 Impact factor: 18.302